Subscribe

Apollo Hospitals Enterprise Limited (APOLLOHOSP.NS)

INR8,900.50 +118.00 (+1.34%)
IN NSE Healthcare Medical - Care Facilities
Address Sunny Side Building 600006
Chennai, IN
CEO Prathap Chandra Reddy
Website apollohospitals.com
IPO 2002-07-01
ISIN INE437A01024

Explore sections of this company profile

Also trades on Bombay Stock Exchange · APOLLOHOSP.BO (INR) National Stock Exchange of India · APOLLOHOSP.NS (INR)
Description

Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR8,900.50 +118.00 (+1.34%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
420.1K
Beta
0.18
Float Shares
100.64M
Free Float %
70.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.17% -0.43% +5.72% +5.77% +12.97% +17.47% +16.95% +78.27% +158.60% +513.60% +64,884.29%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
8,900.50
DCF (Unlevered) 6,919.25 -22.3%
DCF (Levered) 8,541.71 -4.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 87% Bullish
Rating 2026-05 Change
Strong Buy 5 0
Buy 22 +1
Hold 3 0
Sell 1 0
Strong Sell 0 0
Quality scores
Altman Z-Score
7.43
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +15.8% ★ Q1'26: +18.1% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +34.3% ★ Q1'26: +35.9% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +4.8% ★ Q1'26: +9.4% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +11.5% ★ Q1'26: +11.9% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +13.3% ★ Q1'26: +14.7% (vs Q1'25)
  • ✗
    Share dilution Medical - Care Facilities: +0.0%
    +0.0% Q1'26: 0.0% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    2.25× Q1'26: 2.10× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.16) × ERP
WACC = 93% × Ke + 7% × Kd (5.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 7,055.77 Current price: 8,900.50
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2010
actual 		Mar 2011
actual 		Mar 2012
actual 		Mar 2013
actual 		Mar 2014
actual 		Mar 2015
actual 		Mar 2016
actual 		Mar 2017
actual 		Mar 2018
actual 		Mar 2019
actual 		Mar 2020
actual 		Mar 2021
actual 		Mar 2022
actual 		Mar 2023
actual 		Mar 2024
actual 		Mar 2025
actual 		Mar 2026
29 Rev. Ana.
22 EPS Ana. 		Mar 2027
28 Rev. Ana.
24 EPS Ana. 		Mar 2028
26 Rev. Ana.
24 EPS Ana. 		Mar 2029
12 Rev. Ana.
10 EPS Ana.
Revenue
20.26B
est: 20.37B (-0.5%)
26.05B
est: 25.66B (+1.5%)
31.48B
est: 31.77B (-0.9%)
37.99B
est: 38.49B (-1.3%)
51.78B
est: 44.77B (+15.7%)
51.78B
est: 51.91B (-0.2%)
62.15B
est: 61.17B (+1.6%)
72.56B
est: 71.50B (+1.5%)
82.43B
est: 82.77B (-0.4%)
96.18B
est: 95.11B (+1.1%)
112.47B
est: 111.03B (+1.3%)
105.60B
est: 105.76B (-0.2%)
146.63B
est: 147.51B (-0.6%)
166.13B
est: 167.56B (-0.9%)
190.59B
est: 197.27B (-3.4%)
217.94B
est: 218.30B (-0.2%)
251.46B
245.01B – 257.35B
+15.2% YoY
299.37B
287.38B – 349.04B
+19.0% YoY
354.46B
324.67B – 476.99B
+18.4% YoY
397.36B
397.23B – 397.49B
+12.1% YoY
EBITDA
3.33B
est: 2.60B (+27.8%)
4.34B
est: 3.01B (+44.0%)
5.42B
est: 3.70B (+46.7%)
6.44B
est: 4.77B (+35.1%)
7.38B
est: 5.59B (+32.0%)
7.38B
est: 5.99B (+23.2%)
6.88B
est: 7.35B (-6.4%)
7.26B
est: 5.47B (+32.6%)
7.85B
est: 5.23B (+50.1%)
10.51B
est: 3.96B (+165.7%)
13.64B
est: 6.27B (+117.6%)
9.75B
est: 7.48B (+30.4%)
20.46B
est: 9.52B (+114.9%)
19.11B
est: 10.80B (+76.9%)
22.12B
est: 25.58B (-13.5%)
27.98B
est: 28.32B (-1.2%)
32.61B
31.77B – 33.37B
+15.1% YoY
38.82B
37.26B – 45.26B
+19.0% YoY
45.96B
42.10B – 61.85B
+18.4% YoY
51.53B
51.51B – 51.54B
+12.1% YoY
EBIT
2.58B
est: 2.27B (+13.5%)
3.39B
est: 2.87B (+18.2%)
4.15B
est: 4.04B (+2.9%)
5.02B
est: 5.72B (-12.2%)
5.27B
est: 6.58B (-20.0%)
5.27B
est: 6.14B (-14.2%)
4.30B
est: 6.56B (-34.4%)
4.20B
est: 5.05B (-17.0%)
4.42B
est: 4.96B (-10.9%)
6.74B
est: 5.07B (+33.0%)
9.71B
est: 7.90B (+22.9%)
5.67B
est: 11.45B (-50.5%)
15.88B
est: 14.57B (+9.0%)
14.49B
est: 16.54B (-12.4%)
17.07B
est: 19.89B (-14.2%)
22.76B
est: 22.03B (+3.3%)
25.36B
24.71B – 25.95B
+15.1% YoY
30.19B
28.98B – 35.20B
+19.0% YoY
35.75B
32.74B – 48.10B
+18.4% YoY
40.07B
40.06B – 40.09B
+12.1% YoY
Net Income
1.34B
est: 1.44B (-7.3%)
1.76B
est: 1.73B (+1.3%)
2.12B
est: 2.27B (-6.3%)
3.04B
est: 2.66B (+14.6%)
3.40B
est: 3.54B (-4.0%)
3.40B
est: 3.83B (-11.2%)
2.36B
est: 4.13B (-42.7%)
2.21B
est: 2.61B (-15.4%)
1.17B
est: 2.57B (-54.3%)
2.36B
est: 1.34B (+76.3%)
4.55B
est: 2.75B (+65.2%)
1.50B
est: 4.45B (-66.2%)
10.56B
est: 5.67B (+86.3%)
8.19B
est: 6.69B (+22.5%)
8.99B
est: 10.37B (-13.4%)
14.46B
est: 15.74B (-8.1%)
19.42B
17.14B – 19.65B
+23.4% YoY
24.52B
21.74B – 26.32B
+26.3% YoY
31.17B
27.09B – 35.82B
+27.1% YoY
39.04B
34.32B – 47.95B
+25.3% YoY
SGA
2.72B
est: 7.21B (-62.3%)
3.83B
est: 8.20B (-53.3%)
3.30B
est: 9.80B (-66.3%)
4.47B
est: 7.00B (-36.1%)
3.61B
est: 8.46B (-57.4%)
3.61B
est: 16.76B (-78.5%)
4.47B
est: 22.46B (-80.1%)
4.74B
est: 27.07B (-82.5%)
5.17B
est: 33.62B (-84.6%)
5.48B
est: 38.35B (-85.7%)
3.35B
est: 44.70B (-92.5%)
2.64B
est: 40.31B (-93.5%)
4.67B
est: 51.30B (-90.9%)
7.83B
est: 58.23B (-86.6%)
8.10B
est: 14.51B (-44.2%)
7.19B
est: 16.07B (-55.3%)
18.50B
18.02B – 18.93B
+15.1% YoY
22.02B
21.14B – 25.68B
+19.0% YoY
26.08B
23.89B – 35.09B
+18.4% YoY
29.23B
29.22B – 29.24B
+12.1% YoY
EPS
11.15
est: 12.20 (-8.6%)
14.84
est: 16.06 (-7.6%)
16.83
est: 18.08 (-6.9%)
22.08
est: 23.36 (-5.5%)
24.43
est: 25.09 (-2.6%)
24.43
est: 26.00 (-6.0%)
16.99
est: 26.33 (-35.5%)
15.88
est: 19.89 (-20.2%)
8.44
est: 16.55 (-49.0%)
16.96
est: 19.98 (-15.1%)
32.70
est: 24.70 (+32.4%)
10.74
est: 7.22 (+48.8%)
73.42
est: 65.79 (+11.6%)
56.97
est: 58.86 (-3.2%)
62.50
est: 72.13 (-13.4%)
100.56
est: 99.03 (+1.5%)
132.18
119.20 – 136.66
+33.5% YoY
170.28
151.23 – 183.07
+28.8% YoY
216.60
188.39 – 249.13
+27.2% YoY
273.03
238.71 – 333.49
+26.1% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-27 B 3/5 4/5 5/5 5/5 1/5 1/5 1/5
2026-05-26 B 3/5 4/5 5/5 5/5 1/5 1/5 1/5
2026-05-25 B 3/5 4/5 5/5 5/5 1/5 1/5 1/5
2026-05-22 B 3/5 4/5 5/5 5/5 1/5 1/5 1/5
2026-05-21 B 3/5 3/5 5/5 5/5 1/5 1/5 1/5
2026-05-20 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-19 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-18 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-15 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-15 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
14.84B
OE per share TTM
102.06
Owner's Yield
1.25%
Maintenance CapEx ratio
89.65%
Maint CapEx / Avg PPE
51.3%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
348.0K
Shares Outstanding
143.78M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Prathap Chandra Reddy FCCP FICA FRCS MBBS Founder & Executive Chairman 198M —
Konda Sangita Reddy Joint MD & Executive Director 82M —
Suneeta Reddy Joint MD & Executive Director 82M female
Preetha Reddy Executive Vice Chairperson 82M —
Krishnan Akhileswaran Chief Financial Officer 48M male
Sankaranarayanan Muthu Krishnan Senior Vice President of Finance, Compliance Officer & Company Secretary 13M male
Krishnaswami Padmanabhan Group President — male
G. Dasaratha Rama Reddy Senior General Manager of Finance & Accounts — male
Sindoori Reddy Vice President of Operations — female
Binod Madhab Samal Chief Technology Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities